Industry Symposium

Revolutionizing Mitral Valve Replacement with EPIC Plus: Delivering Durability, Implantability, and a Path for Future Interventions

Friday, January 24, 2025

11:55am – 12:55pm PT

Location: 151

Sponsored By: Abbott

Industry Moderator(s)

Vinod H. Thourani, MD

Marcus Chairman of Cardiovascular Surgery
Piedmont Heart Institute and Piedmont Healthcare
Atlanta, Georgia, United States

Disclosure(s): Abbott Vascular: Consultant (Ongoing); AtriCure Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); dasi simulations: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Life Science: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Jenavalve: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic Cardiovascular: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)

Industry Speaker(s)

H. Kenith Fang, MD (he/him/his)

Chairman, Department of Cardiovascular Services. Chief of Cardiothoracic Surgery
Banner - University Medical Center Phoenix
Phoenix, Arizona, United States

Disclosure information not submitted.
Tsuyoshi Kaneko, MD (he/him/his)

Washington University in St. Louis
St. Louis, Missouri, United States

Disclosure information not submitted.
Tom C. Nguyen, MD

Professor of Surgery | Chief Medical Executive
Miami Cardiac & Vascular Institute
Miami, Florida, United States

Disclosure information not submitted.

Disclosure(s):

Vinod H. Thourani, MD: Abbott Vascular: Consultant (Ongoing); AtriCure Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Boston Scientific: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); dasi simulations: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Life Science: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Jenavalve: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Medtronic Cardiovascular: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)